Lv4
670 积分 2025-12-16 加入
Efficacy and safety of multiple treatments for small hepatocellular carcinoma: an updated systematic review and component network meta analysis
4小时前
已完结
Trial design and end points in hepatocellular carcinoma: an EASL–AASLD–ILCA consensus statement
2天前
已完结
Multicenter Single-arm Phase II Trial of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma After Progression on First-line Atezolizumab Plus Bevacizumab
5天前
已完结
Robotic versus Open Pancreatoduodenectomy (PORTAL): multicentre, single masked, phase 3, non-inferiority randomised controlled trial
5天前
已完结
Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer
12天前
已完结
Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer: A Post Hoc Analysis of the TOPAZ-1 Randomized Clinical Trial
12天前
已关闭
Efficacy and safety of dabrafenib plus trametinib in adults with differentiated thyroid cancer: a randomised, double-blind, placebo-controlled, phase 3 trial
12天前
已完结
Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study
13天前
已完结
Cancer incidence and mortality in China, 2024
19天前
已完结
皖公网安备34019202002308
